Public Health Contributions at Your Service, PharmD, MAPP, BS
I'm not just writing policy, I'm shaping history on the future coverage of PKU treatment and leaving a footprint in the FDA regulatory hall of fame. For more on my published works, please visit my contributing author page at The Rare Disease Report
Leading the education initiative
For over 15 years and still going strong!
Click below for the expert facts:
Real World Application of Strategic Capstone Report at focus: FDA medical foods regime and proposed regulatory policy initiative, photo capture: hand delivering a resource tool and statutory scheme to help FDA bring meaningful, positive outcomes and beneficial results through science-driven policy crafted by the expert, me!
which encompass numerous written avocations, testimony at FDA
public meetings, as well as lobby efforts on Capitol Hill, teaching, and
participation in various orphan disease summits, conferences, Congressional
briefings and hearings, campaigns, and local and global observances of relevance
to patients with rare disorders. Current efforts are focused on championing the science of patient input, with focus on federal, health care policy and stakeholder engagement that draws from an array of healthcare professionals and credentialed experts, advisory councils, federal bureaus, industry partners and accrediting agencies for health care institutions that are committed to safety and justice as a priority among federal operations and the health care industry as a whole for patients with rare disease.